2009-2010 Influenza Season Update #4
H1N1 Vaccination of School-Aged Children

To:   Health Care Providers, Hospitals, Infection Control Practitioners, Schools,        Home Health Agencies
From: Wendy Davis, MD, Commissioner of Health
Date: October 23, 2009

– Please Distribute Widely –

School based vaccination clinics
Last week, the Centers for Disease Control & Prevention (CDC) notified states that vaccine manufacturers are experiencing delays in the production of the 2009 H1N1 vaccine. Since that time, the Vermont Department of Health (VDH) has been working with our many partners – including health care providers and schools – to review our vaccination plans and make adjustments as needed.

The first school clinics will begin on October 26; subsequent school clinics will occur less frequently than previously planned and some will need to be rescheduled. We will continue to provide vaccine to health care providers, hospitals, health agencies, and to schools as soon as we can, based on vaccine supply.

Our goal continues to be to move vaccine to providers and clinics as quickly as possible, to ensure vaccination of those individuals who need it most, including school-aged children.

Public and Private schools

Parents in schools during vaccination clinics

Vaccine in provider offices

Other (non-school) vaccine availability sites
Public Clinics

Provider Offices

Recommended Use of Influenza A (H1N1) 2009 Monovalent Vaccine

Excerpt from Morbidity and Mortality Weekly Report
Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
August 28, 2009 / Vol. 58 / No.RR-10

ACIP recommends that vaccination efforts should focus initially on persons in five target groups whose members are at higher risk for influenza or influenza-related complications, are likely to come in contact with influenza viruses as part of their occupation and could transmit influenza viruses to others in medical care settings, or are close contacts of infants aged <6 months (who are too young to be vaccinated). In the event that vaccine availability is unable to meet initial demand, priority should be given to a subset of the five target groups.

Initial Target Groups

When vaccine is first available, ACIP recommends that programs and providers administer vaccine to persons in the following five target groups (order of target groups does not indicate priority):

These five target groups comprise an estimated 159 million persons in the United States. This estimate does not accurately account for persons who might be included in more than one category (e.g., a health-care worker with a high-risk condition). Vaccination programs and providers should begin vaccination of persons in all these groups as soon as vaccine is available.

Subset of Target Groups During Limited Vaccine Availability

Current projections of initial vaccine supply indicate that establishment of a subset of the five initial target groups will not be necessary in most areas. However, demand for vaccination and initial supply might vary considerably across geographic areas. If the supply of the vaccine initially available is not adequate to meet demand for vaccination among the five target groups listed above, ACIP recommends that the following subset of the initial target groups receive priority for vaccination until vaccine availability increases (order of target groups does not indicate priority):

This subset of the five target groups comprises approximately 42 million persons in the United States. Vaccination programs and providers should give priority to this subset of the five target groups only if vaccine availability is too limited to initiate vaccination for all persons in the five initial target groups.

Return to Top